Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of APB-R3

Clinical trial NCT05715736 · COMPLETED

Trial details

NCT number: NCT05715736
Sponsor: Syneos Health
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Still's Disease, Adult-Onset

Start date: 2023-03-08
Primary completion: 2023-12-19
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.